<DOC>
	<DOCNO>NCT00940329</DOCNO>
	<brief_summary>This Phase I , open , randomize control , multiple-dose , parallel-group study investigate potential pharmacodynamic pharmacokinetic interaction multiple dos oral roflumilast inhale formoterol . Healthy male subject assign treatment A treatment B . Subjects treatment A receive 500 μg/d roflumilast day 2 day 18 48 μg/d formoterol day 12 day 18 . Subjects treatment B receive 48 μg/d formoterol day 2 day 18 500 μg/d roflumilast day 9 day 18 . Impedance cardiography , ECG , serum potassium glucose concentration effect blood eosinophil assess potential pharmacodynamic interaction . In addition , safety tolerability evaluate . Pharmacokinetic parameter assess roflumilast , roflumilast N-oxide , formoterol .</brief_summary>
	<brief_title>Pharmacodynamic/Pharmacokinetic Interactions Between Oral Roflumilast Inhaled Formoterol</brief_title>
	<detailed_description />
	<mesh_term>Formoterol Fumarate</mesh_term>
	<criteria>Age 18 45 year Normal body weight indicated Body Mass Index ( BMI ) 18 30 kg/m2 body weight &gt; 50 kg Assessed healthy , base screen examination include medical history , physical examination , BP , PuR , ECG , clinical laboratory result Caucasian Suspected lack compliance Participant study donation blood last 30 start study ( last day intake medication first day medication follow study ) Any active disease , acute chronic ( also psychiatric disease ) Any sign present history cardiac disease ( e.g . QTc interval acc . Bazett ≥ 430 m , PQ ≥ 220 m ) , particular tachycardiac arrhythmia , thirddegree AVblock , idiopathicsubvalvular aortic stenosis hypertrophicobstructive cardiomyopathia Proneness symptomatic orthostatic dysregulation , faint `` blackout '' ( medical history ) , orthostatic hypotension define SBP &lt; 90 mm Hg ( stand blood pressure , 30 raise supine position ) Gastrointestinal surgery except appendectomy herniotomy HIV hepatitis screen positive perform ( case positive HIV test , subject inform physician personal communication Drug screen positive perform Excessive xanthine consumption ( 5 cup coffee equivalent per day ) Noncompliance measurement impedance cardiography ( feasibility proven document screen visit one test procedure )</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Drug interaction</keyword>
	<keyword>Pharmacodynamic interaction</keyword>
	<keyword>Pharmacokinetic interaction</keyword>
	<keyword>Formoterol</keyword>
	<keyword>Healthy subject</keyword>
	<keyword>Phase I study</keyword>
	<keyword>Roflumilast</keyword>
</DOC>